FDA revises provisions of the proposed rule
date:Jul 27, 2015
rcent discount rate), annualized benefits of $200 million (at 7 percent) and $300 million (at 3 percent), and annualized net benefits of $190 million (at 7 percent) and $292 million (at 3 percent) on top of those estimated in the previous proposed rules. In total, we estimate that these rules, including the changes outlined in this proposal, if finalized, will generate annualized costs of $200 million (at both 3 and 7 percent), annualized benefits of $2.1 billion (at 7 percent) and $2.3 billion
20/21 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/02 09:22